Notice of Intent to Award a Sole Source Commercial Simplified Acquisition Procedures (SAP) Purchase Order for Supply Chain Monitoring – Infant Formula

Solicitation No.

HFP-2026-134162

Notice Type

Special Notice

Set-Aside

No Set aside used

Posted Date

July 6, 2026

Response Deadline

July 10, 2026

NAICS Code

541910AI guide

PSC / Class Code

B506

Contract Code

7524

Issuing Office

FDA OFFICE OF ACQ GRANT SVCS

Sub-Agency

FOOD AND DRUG ADMINISTRATION

Agency

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Primary Contact

Haroon Gulzar

City

Rockville

State

MD

ZIP Code

20852

AI Product/Service

service

The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed-price commercial service contract to Circana, LLC (Circana), 203 North LaSalle Street, Suite 1500, Chicago, IL, 60601, USA, for the Purchase of Supply Chain Monitoring – Infant Formula in accordance with the authority under FAR RFO Part 6.103-1 , Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. Circana is the only known source capable of obtain critical data needed to monitor the availability of infant formula products in the United States to support continuity of the FDA’s monitoring the infant formula supply chain - U.S. infant formula shortage initiative. No other sources have expressed an interest in writing in the proposed acquisition. This acquisition is being conducted using simplified acquisition procedures in accordance with FAR RFO Part 12 for the acquisition of commercial products and commercial services. The North American Industry Classification System (NAICS) code for the proposed acquisition is 541910 - Marketing Research and Public Opinion Polling $22.5. Deliverables: CLIN 1 - Out of Stock Tracking Solution (OOS) - 2 user licenses – Estimated Delivery Date 07/30/2026 (Valid 1 Year) CLIN 2 - Liquid Data Go (LDG) - 1 user license - Estimated Delivery Date 07/30/2026 (Valid 1 Year) Responses Responses to this notice should be sent to Haroon Gulzar at haroon.gulzar@fda.hhs.gov no later than 5:00 pm (ET) on July 10, 2026. This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.

1. July 6, 2026Posted Date
2. July 10, 2026Proposals / Responses Due